BP1101

ヒドロキシクロロキン硫酸塩

British Pharmacopoeia (BP) Reference Standard

• 別名: 7-クロロ-4-[4-(N-エチル-N-b-ヒドロキシエチルアミノ)-1-メチルブチルアミノ]キノリン硫酸塩
• 実験式（ヒル表記法）: C₁₈H₂₆ClN₃O · H₂SO₄
• CAS番号: 747-36-4
• 分子量: 433.95
• MDL番号: MFCD00078203
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• 認証: BP
• APIファミリー: hydroxychloroquine
• 形状: solid
• シェルフライフ: limited shelf life, expiry date on the label
• 包装: pkg of 25 mg
• メーカー／製品名: BP
• 保管条件: OK to freeze
• 色: off-white
• mp: 238-241 °C
• 溶解性: water: soluble
• アプリケーション: pharmaceutical; pharmaceutical small molecule
• フォーマット: neat
• 輸送温度: ambient
• 保管温度: 2-8°C
• SMILES記法: OS(O)(=O)=O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
• InChI: 1S/C18H26ClN3O.H2O4S/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18;1-5(2,3)4/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21);(H2,1,2,3,4)
• InChI Key: JCBIVZZPXRZKTI-UHFFFAOYSA-N
• 遺伝子情報: human ... TLR7(51284) , TLR9(54106)

詳細

詳細

2-[4-[(7-Chloro-4-quinolinyl)amino]pentyl] amino ethanol (Hydroxychloroquine Sulfate) is a salt of hydroxychloroquine (HCQ, Plaquenil), a 4-aminoquinoline based antiviral drug.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

2-[4-[(7-Chloro-4-quinolinyl)amino]pentyl] amino ethanol BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

生物化学的／生理学的作用

ヒドロキシクロロキン硫酸塩は、抗炎症性（TNFを介する）の疾患修飾性抗リウマチ薬（DMARD）であり、ヘムポリメラーゼ阻害剤です。 マラリアの治療に使用されます。

包装

Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H302,H315,H319
• 注意書き: P264 - P280 - P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338
• 危険有害性の分類: Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable